Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer (DeCRESCEndo)

NCT04386993 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04386993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04386993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer (DeCRESCEndo)
Lead sponsor
Washington University School of Medicine
Phase
Not applicable
Overall status
Completed
Start date
July 7, 2020
Completion date
October 13, 2025
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer